WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
5,20 THB
0,00%
(0,00) 1D
15 ოქტ, 16:40:00 GMT+7 · THB
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for WUXI06...
Open
5,25 THB
High
5,35 THB
Low
5,05 THB
Mkt. cap
198,43 მლრ.
Avg. vol.
93,60 ათ.
Volume
288,50 ათ.
52-wk high
6,25 THB
52-wk low
3,02 THB
Shares outstanding
4,12 მლრდ.
No. of employees
15 ათ.
Open
5,25 THB
High
5,35 THB
Low
5,05 THB
Mkt. cap
198,43 მლრ.
Avg. vol.
93,60 ათ.
Volume
288,50 ათ.
52-wk high
6,25 THB
52-wk low
3,02 THB
Shares outstanding
4,12 მლრდ.
No. of employees
15 ათ.
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
·
29 წუთის წინ
FILE PHOTO: Traders work on the floor of the New York Stock Exchange (NYSE) in New York City
3D Printing Industry
·
1 საათის წინ
Amaero Nets $15.7M in Nasdaq IPO but Expects to Need More Capital in 2027
Opening Bell Daily
·
29 წუთის წინ
Stock Market Outlook: Stock pickers are lagging the index
Yahoo Finance
·
1 საათის წინ
Buy 5 Top-Ranked Non-Tech Nasdaq Stocks to Maximize Q4 Gains
Profile
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
About Wuxi Biologics (Cayman) Inc. KKPS DR